Novel pharmacotherapies for cardiac amyloidosis.

about

'A new staging system for cardiac transthyretin amyloidosis': is it already on the verge of obsolescence?

P2860

Q49916288-39D0F2DA-0CC2-464C-89F0-B5D2C641FE9F

P2860

Novel pharmacotherapies for cardiac amyloidosis.

Item

http://www.wikidata.org/entity/Q38709793

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Novel pharmacotherapies for cardiac amyloidosis.

@en

type

Item

label

Novel pharmacotherapies for cardiac amyloidosis.

@en

prefLabel

Novel pharmacotherapies for cardiac amyloidosis.

@en

P1476

Novel pharmacotherapies for cardiac amyloidosis

@en

P2093

Rodney H Falk

http://www.w3.org/2001/XMLSchema#string

P2860

Synergy of combined doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models

Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action

Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis

Potent Kinetic Stabilizers That Prevent Transthyretin-Mediated Cardiomyocyte Proteotoxicity

AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial

Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes.

First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction

P304

129-138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PHARMTHERA.2017.06.011

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P50

Avinainder Singh

Kevin M Alexander

P577

2017-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28648829

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

5832446

http://www.w3.org/2001/XMLSchema#string

Novel pharmacotherapies for cardiac amyloidosis.

about

P2860

P2860

Novel pharmacotherapies for cardiac amyloidosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932